Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 3, Multicenter, Open-Label Safety Study to Evaluate the Long-Term Safety and Tolerability of SAGE-718 in Participants with Huntington's Disease (IRB 276546)


Collapse Overview 
Collapse sponsor award id
SAGE-718


Collapse Biography 

Collapse Time 
Collapse start date
2024-05-01

Collapse end date
2034-04-30